CleanSpark Reaches 50 EH/s Milestone; Escape Velocity in Action
First publicly traded miner to reach this scale with fully self-operated infrastructure LAS VEGAS, June 24, 2025 /PRNewswire/ -- CleanSpark, Inc....
Morning Movers
BTQ Technologies Unveils Quantum Stablecoin Settlement Network (QSSN)
Demonstrates How Quantum-Secure Stablecoin Models for JPMorgan, Tether, Circle, and Others Enter The Quantum future Quantum-Safe Stablecoin Infrastructure: BTQ unveils...
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing
Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request...
Avant Technologies Creating New Company for Expansion of Diabetes Program
LAS VEGAS, June 24, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company...
Global Renewable Energy Market to Reach $2 Trillion by 2029
"Accelerating the Shift to Renewable Energy: A Smart, Sustainable Investment for a Cleaner Planet and a Stronger Economy Amid the...
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
Lead amylin receptor agonist engineered antibody significantly reduced acute food intake in a mouse model of obesity, comparable to the...
Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC
Aligned with FDA on NDA submission strategy for TKI pre-treated patients with advanced ROS1-positive NSCLC and participation in Real-Time Oncology Review;...
NUTEX HEALTH INC. ADDED TO RUSSELL 3000® INDEX AND RUSSELL MICROCAP® INDEX
HOUSTON, June 24, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare...
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
– At Week 144, 92.3% of Patients Remained Free of 12-Week Confirmed Disability Worsening (CDW) With 92.7% Remaining Free of...
Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa “Blue Zone”, Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World’s Longest-Lived Population
NEW YORK, June 24, 2025 /PRNewswire/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene-...
CMOC Completes Acquisition of Lumina Gold
VANCOUVER, BC, June 23, 2025 /PRNewswire/ - Lumina Gold Corp. (TSXV: LUM) (OTCQB: LMGDF) (the "Company" or "Lumina") announces that CMOC Singapore Pte....
Critical Metals Corp Signs Infill Diamond Drilling Program to Significantly Increase the Size of the Resource at Tanbreez
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a...
Is It Time for XRP? PFMCrypto Unveils First-Ever XRP Cloud Mining Contracts with Daily Payouts — A New XRP Era Begins
Farington, England, June 23, 2025 (GLOBE NEWSWIRE) -- A breakthrough in XRP mining is finally here—PFMCrypto unveils a cloud-based, daily-profit...
Nuvalent Announces Timing of Pivotal Data for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC from ARROS-1 Clinical Trial of Zidesamtinib
Company to host webcast and conference call on June 24, 2025 at 8:00am ET CAMBRIDGE, Mass., June 23, 2025 /PRNewswire/...
iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call
Review of promising Myostatin and Activin E antibody data iBio to announce 3rd target in Astral Bio Collaboration Conference call...
Sidus Space Advances $120M Agreement with Lonestar, Selects Atomic-6 as Solar Array Partner for Cislunar Data Satellite Mission
CAPE CANAVERAL, Fla.--(BUSINESS WIRE)--Sidus Space (NASDAQ: SIDU), (the “Company” or “Sidus”), an innovative space and defense technology provider, today announced...
RESULTS FROM AMGEN’S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS
MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight...
Lottery.com Regains Nasdaq Compliance as Stock Trading Activity Soars
FORT WORTH, Texas, June 23, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (NASDAQ: LTRY; LTRYW) (“Lottery.com” or “the Company”) received formal...
High Tide Marks Canada Day by Launching Summer Long “Buy Local” Initiative
CALGARY, AB, June 23, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE:...
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Month Patient Follow-up Results...
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program
The significant HYPE token position, acquired at an average price of approximately $34 per token, makes Eyenovia the first Nasdaq...
Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
New pharmacokinetic and cardiac biomarker data further demonstrate ifetroban's potential to protect the heart and reduce cardiac damage in DMD...
Cadiz Inc. Declares Quarterly Dividend for Q2 2025 on Series A Cumulative Perpetual Preferred Stock
LOS ANGELES, June 23, 2025 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI / CDZIP) ("Cadiz," the "Company"), a California water solutions...
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Fourth cohort dose is three million CAR positive cells; thirty times higher than the first cohort dose SAN JOSE, Calif.,...
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside...
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside...
Zoomcar to Announce Financial Results for Fiscal Year Ending March 31, 2025
BENGALURU, India, June 23, 2025 /PRNewswire/ -- Zoomcar Holdings, Inc. ("Zoomcar" or the "Company") (OTCQX: ZCAR), the leading marketplace for self-drive...
Genprex Collaborators Present Research on Non-Viral Approach to Diabetes Gene Therapy Using Lipid Nanoparticle Delivery System at the 2025 American Diabetes Association 85th Scientific Sessions
Novel Diabetes Gene Therapy Shows Potential for Re-Dosing Using Non-Viral Delivery System AUSTIN, Texas, June 23, 2025 /PRNewswire/ -- Genprex,...
ECD Automotive Design Secures $500M Equity Facility to Fund a Bitcoin Treasury
$500M facility earmarked for the strategic accumulation of Bitcoin to serve as the Company’s primary reserve asset and for the...
ECD Automotive Design Announces Key Initiatives to Right-Size Cost Structure and Support Disciplined Growth
KISSIMMEE, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (NASDAQ: ECDA), the world’s largest Land Rover and...
Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association’s 85th Scientific Sessions
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on...
Scholastic Provides Update on Strategic and Operational Initiatives
NEW YORK, June 23, 2025 /PRNewswire/ -- Scholastic Corporation (NASDAQ: SCHL), the global children's publishing, education and media company, today provides...
Rezolve Ai to Join Russell 2000® and Russell 3000® Indices Following Breakout Year of Hypergrowth and Strategic Alliances
$70 Million ARR Locked in via Customer ContractsMicrosoft and Google Partnerships Accelerate Momentum NEW YORK, June 23, 2025 (GLOBE NEWSWIRE)...
Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO™) as a Treatment for Postpartum Depression on July 9, 2025
SALT LAKE CITY, June 23, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform...
Quantum Computing Inc. Announces Private Placement of Common Stock for Proceeds of $200 Million
The offering is being led by several preeminent global investment firms Company total cash position expected to exceed $350 million...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner’s National Priority Voucher Application for Intravenous Ketamine (NRX-100)
Company has applied for new Commissioner's National Priority Vouchers (CNPV) for NRX-100. Continues to anticipate decisions on drug approval by...
Innovative Eyewear, Inc. Announces $4.8 Million of Gross Proceeds Raised from Warrant Transactions
$2.2 million gross proceeds from warrant inducement transaction $2.6 million gross proceeds from additional warrant exercises MIAMI, June 23, 2025...
Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO™) as a Treatment for Postpartum Depression on July 9, 2025
SALT LAKE CITY, June 23, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform...
JONES SODA CO. ANNOUNCES DIVESTITURE OF CANNABIS BEVERAGE BUSINESS
SEATTLE, June 23, 2025 /PRNewswire/ - Jones Soda Co. (CSE: JSDA) (OTCQB: JSDA) ("Jones" or the "Company"), a craft beverage company...
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025 NEW YORK, June 23, 2025...